patient-empowerment
(2)
Leal Health
Leal Health (formerly TrialJectory) is an AI-powered treatment decision-support platform that gives cancer patients and their oncologists an unbiased, single point of access to FDA-approved therapies and clinical trials matched to a patient's exact diagnosis. Founded in 2017 and headquartered in New York, the company built a patented, generative-AI engine that reads thousands of trials and treatment options, then matches patients in a roughly two-minute intake. It has facilitated millions of treatment matches across 22+ cancer types, is free for patients and clinicians, and earns revenue from biopharma partners and health plans. In February 2026 Leal Health was acquired by Nexus Precision Health.
Steve Alperin
Steve Alperin is the founder and CEO of SurvivorNet, the New York based media platform that turns dense cancer treatment research into clear, watchable guidance for patients and families. A former head writer and senior producer for Peter Jennings at ABC's World News Tonight and a two-time Writers Guild of America Award winner, Alperin built SurvivorNet in 2018 after his family's struggle to find reliable answers during his father's cancer. He pairs newsroom storytelling craft with the clinical rigor of leading physicians, reaching millions of survivors every month.